theme-icon
Scan to download
Home Flash
Depth
Calendar
Data
Find
BTC $64,420.34 +0.72%
ETH $1,877.77 +1.10%
BNB $569.44 +0.96%
XRP $1.09 +0.61%
SOL $74.66 +0.92%
TRX $0.3311 +0.14%
DOGE $0.0716 +3.16%
ADA $0.1650 +0.73%
BCH $209.28 -0.62%
LINK $8.39 +0.86%
HYPE $58.31 +1.97%
AAVE $92.18 +0.81%
SUI $0.7117 +0.32%
XLM $0.1781 -0.12%
ZEC $485.91 -0.43%
BTC $64,420.34 +0.72%
ETH $1,877.77 +1.10%
BNB $569.44 +0.96%
XRP $1.09 +0.61%
SOL $74.66 +0.92%
TRX $0.3311 +0.14%
DOGE $0.0716 +3.16%
ADA $0.1650 +0.73%
BCH $209.28 -0.62%
LINK $8.39 +0.86%
HYPE $58.31 +1.97%
AAVE $92.18 +0.81%
SUI $0.7117 +0.32%
XLM $0.1781 -0.12%
ZEC $485.91 -0.43%
Home
Article
Flash
Specials
Columns
Knowledge Base
Calendar
Markets
Charts
Activity
Tools

Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc

2025-12-02 22:26:45
Collection

According to market news, Nasdaq-listed biotech company Sonnet Biotherapeutics has received shareholder approval to merge with Hyperliquid Strategies Inc.

Previously, it was reported that Hyperliquid Strategies submitted an S-1 filing to raise up to $1 billion, which may be used to purchase HYPE tokens.

source Source
warnning Risk warning
Related tags
Sonnet Biotherapeutics Hyperliquid Strategies Inc
Related reading
Data: HYPE Financial Company Hyperliquid Strategies Inc recently increased its holdings by 220,000 HYPE, worth approximately 8.58 million USD
2026-04-09 17:18
UPBIT lists Euler (EUL) and supports the KRW market
2026-07-26 08:56
Zhao Changpeng: Long-term investment can use the DCA investment strategy
2026-07-26 08:27
Liang Wenfeng is dissatisfied with the leak of the 4-hour internal speech, and DeepSeek announced the suspension of the second round of financing
2026-07-25 23:17
Related tags
Sonnet Biotherapeutics Hyperliquid Strategies Inc
Copyright © 2023
About Us
Media Kit
Apply column
AWS
Privacy Policy
Risk Warning
Hiring
Qiong ICP No. 2021009392
Qiong ICP No. 2021009392
app_icon
ChainCatcher Building the Web3 world with innovations.